{{Rsnum
|rsid=1800974
|Gene=ITGA7
|Chromosome=12
|position=55695573
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.4118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ITGA7
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.3 | 57.8 | 23.9
| HCB | 84.7 | 15.3 | 0.0
| JPT | 89.4 | 9.7 | 0.9
| YRI | 7.0 | 55.2 | 37.8
| ASW | 13.0 | 53.7 | 33.3
| CHB | 84.7 | 15.3 | 0.0
| CHD | 89.0 | 11.0 | 0.0
| GIH | 52.5 | 41.6 | 5.9
| LWK | 0.0 | 0.0 | 0.0
| MEX | 40.4 | 54.4 | 5.3
| MKK | 10.6 | 42.4 | 47.0
| TSI | 17.6 | 54.9 | 27.5
| HapMapRevision=28
}}{{Venter SNP
|rsid=1800974
|allele=T
|frequency=0.475
|uid=1103649448231
|type=heterozygous_SNP
|hugo=ITGA7
|ensembl gene=ENSG00000135424
|ensembl transcript=ENST00000347027
|sift=TOLERATED
|disease=Defects in ITGA7 are associated with a form of congenital myopathy; a group of heterogeneous muscle disorders which are thought to result from abnormal muscle development. Muscle weakness is either non-progressive or slowly progressive and apparent from birth or early infancy.
}}

{{GET Evidence
|gene=ITGA7
|aa_change=Arg655His
|aa_change_short=R655H
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1800974
|overall_frequency_n=4875
|overall_frequency_d=10758
|overall_frequency=0.453151
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=3
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_testable=Y
|nblosum100=1
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}